0000950170-24-081605.txt : 20240703
0000950170-24-081605.hdr.sgml : 20240703
20240703170008
ACCESSION NUMBER: 0000950170-24-081605
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240701
FILED AS OF DATE: 20240703
DATE AS OF CHANGE: 20240703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BAILEY DON M
CENTRAL INDEX KEY: 0001223697
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12830
FILM NUMBER: 241100788
MAIL ADDRESS:
STREET 1: 1300 N. KELLOGG DRIVE
STREET 2: SUITE D
CITY: ANAHEIM
STATE: CA
ZIP: 92607
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lineage Cell Therapeutics, Inc.
CENTRAL INDEX KEY: 0000876343
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 943127919
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2173 SALK AVENUE
STREET 2: SUITE 200
CITY: CARLSBAD
STATE: CA
ZIP: 92008
BUSINESS PHONE: 5105213390
MAIL ADDRESS:
STREET 1: 2173 SALK AVENUE
STREET 2: SUITE 200
CITY: CARLSBAD
STATE: CA
ZIP: 92008
FORMER COMPANY:
FORMER CONFORMED NAME: BIOTIME INC
DATE OF NAME CHANGE: 19930328
4
1
ownership.xml
4
X0508
4
2024-07-01
0000876343
Lineage Cell Therapeutics, Inc.
LCTX
0001223697
BAILEY DON M
C/O LINEAGE CELL THERAPEUTICS
2173 SALK AVENUE, SUITE 200
CARLSBAD
CA
92008
true
false
false
false
false
Stock Option (Right to Buy)
0.9541
2024-07-01
4
A
false
75000
0.00
A
2034-07-01
Common Shares
75000
75000
D
Will vest and become exercisable on July 1, 2025, subject to the reporting person's continuous service with the issuer.
/s/ Alexandra Hernandez, as Attorney-in-Fact
2024-07-03